Understanding Chronic Lymphocytic Leukemia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04028531

Enrollment

2750

Registered

2019-07-22

Start date

1999-09-29

Completion date

2032-09-29

Last updated

2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Lymphocytic Leukemia

Keywords

Chronic Lymphocytic Leukemia

Brief summary

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.

Detailed description

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* New and existing patients seen for treatment of monoclonal B-cell lymphocytosis * Any low grade lymphoproliferative disorder * Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia	20 years	Exploratory science to better understand Chronic Lymphocytic Leukemia

Countries

United States

Contacts

CONTACTJennifer Brown, MD, PhD

Jennifer_brown@dfci.harvard.edu617-582-8437

PRINCIPAL_INVESTIGATORJennifer Brown, MD,PhD

Dana-Farber Cancer Institute

Outcome results